Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment

BACKGROUND: Primary central nervous system lymphoma (PCNSL) is a highly aggressive non-Hodgkin’s B-cell lymphoma which normally treated by high-dose methotrexate (HD-MTX)-based chemotherapy. However, such treatment cannot always guarantee a good prognosis (GP) outcome while suffering several side ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Liying, Li, Qing, Xu, Jingshen, Wang, Shuaikang, Song, Zhiqiang, Chen, Xinyi, Ma, Yan, Lin, Zhiguang, Chen, Bobin, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985165/
https://www.ncbi.nlm.nih.gov/pubmed/36879663
http://dx.doi.org/10.1093/noajnl/vdac181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985165/
https://www.ncbi.nlm.nih.gov/pubmed/36879663
http://dx.doi.org/10.1093/noajnl/vdac181

Ejemplares similares